Urokinase-type plasminogen activator receptor

Seller C, Montuori N, Ricci P et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood. 2005 105 2198-2205. [Pg.61]

Kofoed, K., et al. (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections a prospective study. Crit Care. 11, R38. [Pg.214]

Ostrowski SR, Ullum H, Goka BQ, Hoyer-Hansen G, Obeng-Adjei G, Pedersen BK, et al. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome. J Infect Dis 2005 191(8) 1331-1341. [Pg.95]

Sidenius N, Sier CF, Ullum H, Pedersen BK, Lepri AC, Blasi F, et al. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 2000 96(13) 4091 1095. [Pg.95]

Plesner T, Behrendt N, Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells 1997 15(6) 398-408. [Pg.95]

Ploug M, Rahbek-Nielsen H, Nielsen PF, Roepstorff P, Dano K. Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells. J Biol Chem 1998 273(22) 13933-13943. [Pg.96]

Koolwijk P, Sidenius N, Peters E, Sier CF, Hanemaaijer R, Blasi F, et al. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12 Implication for angiogenesis in fibrin matrices. Blood 2001 97(10) 3123—3131. [Pg.98]

Andolfo A, English WR, Resnati M, Murphy G, Blasi F, SideniusN. Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor. Thromb Haemost 2002 88(2) 298-306. [Pg.99]

Plebani M, Herszenyi L, Carraro P, De PM, Roveroni G, Cardin R, et al. Urokinase-type plasminogen activator receptor in gastric cancer Tissue expression and prognostic role. Clin Exp Metastasis 1997 15(4) 418-425. [Pg.101]

Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, et al. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res 1998 58(9) 1843—1849. [Pg.101]

Lanza F, Castoldi GL, Castagnari B, Todd RF, III, Moretti S, Spisani S, et al. Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells. Br J Haematol 1998 103(1) 110-123. [Pg.102]

Urokinase-Type Plasminogen Activator Receptors (uPAR). 139... [Pg.101]

Lakka SS, Gondi CS, Dinh DH, et al. (2005) Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J Biol Chem 280 21882-21892... [Pg.58]

Serrati S, Margheri F, Fibbi G, et al. (2008) Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. J Pathol 214 545-554... [Pg.60]

L3. Lamfers, M. L., Grimbergen, J. M., Aalders, M. C., et al.. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1. ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinases. Circ. Res. 91, 945-952 (2002). [Pg.129]

W3. Weckroth, M., Vaheri, A., Myohanen, H., Tukiainen, E., and Siren, V., Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator... [Pg.132]

MDM = SLURP Mai de Meleda palmoplantar keratosis due to mutation in chromosome 8q24-qter in gene of secreted lymphocyte antigen-6 urokinase-type plasminogen-activator receptor-related protein, that is not to be mistaken for MDM as above. Click for SLURP by Eckl KM et al and/or Wajid M et al. [Pg.356]

Asbestos increased urokinase-type plasminogen activator receptor at the surface of rabbit and human mesothelial cells, suggesting that altered expression of this receptor could be involved in asbestos-induced remodelling of the pleural meso-theUum (Perkins et al. 1999). [Pg.273]

Artym, V. V., Kindzelskii, A. L., Chen, W. T., and Petty, H. R. (2002). Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes Dependence on betal integrins and the cytoskeleton. Carcinogenesis 23, 1593-1601. [Pg.146]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...